Lemaitre Vascular (LMAT) Reports In-Line Q4 EPS; Issues Mixed Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 inches lower as Middle East tensions outweigh tech gains
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
LeMaitre Vascular Announces Q4 2019 Financial Results
February 6, 2020 4:05 PM ESTBURLINGTON, Mass., Feb. 06, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants and services, today reported Q4 2019 results, provided guidance, and announced a $0.095/share dividend.
Q4 2019 Results
Record sales of $30.2mm, +6% (flat organic) vs. Q4 2018Operating income of $4.9mm, -31% (-12% excluding special items)Net income of $4.6mm, -23% (+4% excluding special items)Earnings of $0.23 per diluted share, -25% (+3% excluding special items)The Company posted record sales in the Americas (+6%), while Europe/Middle East/Africa (+4%) and Asia/Pac (+20%)... More
